MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
IDEXX Laboratories Depreciation & Amortization 2011-2026 | IDXX
Annual Depreciation & Amortization IDEXX Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 130 M | 115 M | 112 M | 105 M | 96 M | 88 M | 83.2 M | 83.1 M | 78.2 M | 69 M | 58.9 M | 54.6 M | 52.4 M | 48.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 M | 48.2 M | 83.8 M |
Quarterly Depreciation & Amortization IDEXX Laboratories
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 34.1 M | - | - | - | 29.9 M | - | - | - | 28.3 M | - | 83.2 M | - | 26.5 M | - | 76.9 M | - | 25.1 M | - | 71.4 M | 46.8 M | 23.2 M | - | 65.4 M | 43 M | 21.4 M | - | 62.6 M | 41.7 M | 20.8 M | - | 61.6 M | 40.9 M | 20.3 M | - | 58 M | 38.2 M | 18.5 M | - | 51.2 M | 32.9 M | 16.2 M | - | 43.6 M | 28.1 M | 13.4 M | - | 41.1 M | 27.4 M | 13.5 M | - | 38.5 M | 25.7 M | 12.7 M | - | 35.4 M | 23.3 M | 11.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 83.2 M | 11.5 M | 36.5 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 29.0 | -3.07 % | $ 316 M |  China |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.14 | -2.16 % | $ 1.45 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Celcuity
CELC
|
130 K | $ 104.95 | -1.72 % | $ 4.14 B | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 210.56 | -0.33 % | $ 154 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 29.41 | -6.17 % | $ 817 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 202.21 | -0.11 % | $ 22.4 B | USA |
 |
DexCom
DXCM
|
252 M | $ 73.08 | 1.11 % | $ 28.5 B | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 11.75 | 2.8 % | $ 333 M | Israel |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 18.83 | -5.23 % | $ 1.01 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
354 M | $ 117.53 | -2.06 % | $ 18.7 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 23.18 | -0.39 % | $ 701 M | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | $ 103.45 | 0.15 % | $ 19.5 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 74.31 | 1.54 % | $ 5.14 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 103.36 | -2.84 % | $ 13 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 99.61 | 1.22 % | $ 8.22 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
300 K | $ 1.85 | 2.78 % | $ 8.12 M | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
403 M | $ 169.68 | 3.11 % | $ 8.41 B | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 166.19 | -1.87 % | $ 28.6 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 13.26 | 4.0 % | $ 1.72 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 283.38 | 0.32 % | $ 23.8 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.17 | -2.25 % | $ 4.98 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 8.57 | -0.06 % | $ 537 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 452.99 | 1.47 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
National Research Corporation
NRC
|
140 K | $ 13.65 | 9.64 % | $ 335 M | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 378.44 | 0.14 % | $ 28.4 B |  Schweiz |